| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |